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Abstract 
Cholesterol is an essential constituent of all
mammalian cell membranes and its availability
is therefore a prerequisite for cellular growth
and other functions. Several lines of evidence
are  now  indicating  an  association  between
alterations of cholesterol homeostasis and cell
cycle progression. However, the role of choles-
terol  in  cell  differentiation  is  still  largely
unknown. To begin to address this issue, in this
study  we  examined  changes  in  cholesterol
metabolism and in the mRNA levels of proteins
involved in cholesterol import and esterifica-
tion  (multi-drug  resistance,  MDR-3)  and
acylCoA:  cholesterol  acyltransferase  (ACAT)
and cholesterol export (caveolin-1) in Friend
virus-induced  erythroleukemia  cells  (MELC),
in the absence or in the presence of the chem-
ical inducer of differentiation, hexamethylene
bisacetamide (HMBA). FBS-stimulated growth
of MELC was accompanied by an immediate
elevation of cholesterol synthesis and choles-
terol esterification, and by an increase in the
levels of MDR-3 and ACAT mRNAs. A decrease
in  caveolin-1  expression  was  also  observed.
However, when MELC were treated with HMBA,
the  inhibition  of  DNA  synthesis  caused  by
HMBA  treatment,  was  associated  with  a
decrease  in  cholesterol  esterification  and  in
ACAT and MDR-3 mRNA levels and an increase
in caveolin-1 mRNA. Detection of cytoplasmic
neutral lipids by staining MELC with oil red O,
a dye able to evidence CE but not FC, revealed
that  HMBA-treatment  also  reduced  growth-
stimulated accumulation of cholesterol ester to
approximately  the  same  extent  as  the  ACAT
inhibitor, SaH. Overall, these results indicate
for the first time a role of cholesterol esterifica-
tion and of some related genes in differentia-
tion of erythroid cells. 
Introduction
Cholesterol balance in cells is a function of
the  amount  taken  up  from  extracellular
sources, the amount newly made by the cell, the
amount stored as cholesterol esters (CE) and
the amount removed by cholesterol acceptors
like high density lipoprotein (HDL). Based on
the notion that activation of cell growth impos-
es  additional  need  for  cellular  cholesterol  to
support membrane synthesis, a potential mech-
anism contributing to abnormal growth might
involve  altered  cellular  sterol  balance  and/or
metabolism. A relationship between cholesterol
metabolism and tumoral growth has been pre-
viously shown in our laboratories in different
animal models of tumors1,2as well as in various
types  of  human  neoplasms,3-5 including
leukemias.6 A constant finding of these studies
was that tumors are characterized by specific
pattern of cholesterol metabolism, namely an
increase of cholesterol synthesis and an accu-
mulation of CE in tumoral cells, and a corre-
sponding decrease of HDL cholesterol in the
plasma  compartment.  More  recently,  in  vitro
studies7-8 have provided a plausible association
between cholesterol esterification and the con-
trol  of  cell  cycle  progression,  indicating  that
cholesterol esterification may act by accelerat-
ing signal transduction pathways involved in
cell cycle control.9 Several in vitro studies have
shown that proliferation and differentiation are
inversely correlated processes.10,11 Many can-
cers exhibit both loss of normal proliferation
controls and a block in completing differentia-
tion.12In this context, Friend virus-induced ery-
throleukemia of mice give rise to permanent
cell lines of transformed erythroid/megakary-
ocyte precursor cells that are blocked at about
the  proerythroblast/megaerythroblast  stage  of
differentiation.13-17 Treatment of these murine
erythroleukemia cell (MELC) lines with chemi-
cal inducers of differentiation such as hexam-
ethylene bisacetamide (HMBA), causes them
to reinitiate erythroid differentiation culminat-
ing in the synthesis of hemoglobin, terminal
cell  division,  and  loss  of  tumorigenicity.18-21
Such cell system offer an attractive opportunity
to better explore the coordination of rate of cell
proliferation  and  differentiation  and  choles-
terol esterification. Therefore, we assayed the
levels  of  newly  synthesized  cholesterol  (free
and ester), cholesterol esterification and the
rate of growth during differentiation induced in
MELC by HMBA. Cholesterol esterification is
one of the mechanisms that cells use to control
the  amount  of  toxic  free  cholesterol  (FC);
under conditions of excess cholesterol, this is
transported from the plasma membrane to the
endoplasmic reticulum (ER) where is esteri-
fied.22,23
Several lines of evidence are now indicating
that  caveolin-1,  the  key  structural  protein  of
caveolae  (cholesterol-rich  membrane
microdomains) and P-glycoprotein (P-gp), the
product of the multidrug resistance (MDR-1 in
humans and the MDR-3 in rodents) gene have
inverse implications in the cholesterol metabo-
lism of normal cells. The MDR gene is involved
in  the  process  of  cholesterol  esterification,
being  required  for  transport  of  FC  from  the
plasma membrane to ER, the site of cholesterol
esterification by acyl-CoA:cholesterol acyltrans-
ferase  (ACAT).24,25 In  contrast,  caveolin-1  is
required for translocation of cholesterol from
the ER to the plasma membrane and is involved
in cholesterol efflux.26-28
However, in spite of the fact that MDR and
caveolin-1 are recognized as playing a major
role in intracellular cholesterol ester metabo-
lism,  it  is  still  unclear  why  during  tumor
growth, membrane cholesterol is preferentially
shifted to the ER, leading to an accumulation of
CE, rather than being released to the appropri-
ate extra cellular HDL acceptor. These observa-
tions prompted us to investigate levels of ACAT-
1, MDR-3, and caveolin-1 mRNAs during differ-
entiation of MELC induced by HMBA. 
Materials and Methods
Cell cultures, conditions for induc-
tion, and reagents
MELCs (derived from the 745/A strain) were
grown in suspension using RPMI 1640 medium
(Bio-Whittaker  Europe,  Verviers,  Belgium)
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containing 2 mM glutamine and supplemented
with 5% fetal bovine serum (FBS) Boehringer-
Mannheim, Mannheim, Germany) at 37°C in a
5%  CO2-humidified  atmosphere.  Cells  were
usually seeded at a density of 105 cells/mL and
passaged every 4-5 days. Induction of MELC dif-
ferentiation was carried out by supplementing
cultures with 5 mM HMBA (Sigma, St. Louis,
MO, USA).
At the start of the experiments, cells from the
stock  cultures  were  diluted  and  seeded  at  a
density of lﾥ105 cells/mL in 10% FBS. Unless
otherwise indicated, cells were harvested at 0,
24, 48, 72, and 96 h after seeding.
Analysis of cellular growth 
At the times indicated, cells supplemented
with 10% FBS were washed with PBS, harvest-
ed  with  trypsin/EDTA  (0.05%/0.02%)  and  cell
number was counted using a Coulter counter.
For the thymidine incorporation studies, cells
were labelled with  3H-thymidine at 5 ʼCi/mL
during  the  last  3  hours  of  incubation,  and
radioactivity  incorporated  into  the  DNA  was
determined  by  trichloroacetic  acid  precipita-
tion  of  the  cell  lysate.  Protein  content  was
determined by Lowry et al.29
Cholesterol biosynthesis and esteri-
fication 
To  assess  cholesterol  biosynthesis,  cells
were incubated in medium containing 10% of
FBS with (14C)acetate (final radioactivity of 7.4
MBq/mL) for 4 hours at 37°C in a CO2 incuba-
tor.  To  assess  cholesterol  esterification,  cells
were incubated for 4 h at 37°C with (14C)oleic
acid (specific activity of 2.22 GBq/mmol, final
radioactivity  of  0.185  MBq/mL;  Amersham
Biosciences)  complex  with  BSA  (essentially
fatty acid-free; Sigma). Cells were washed, and
lipids were extracted and analyzed by thin layer
chromatography (TLC) as described previous-
ly.9 Spots of cholesterol and cholesteryl oleate
were identified by standards (Sigma), scraped,
and counted in a ʲ-counter.
RNA extraction, reverse transcrip-
tion -PCR analysis
Total RNA was isolated from cells using the
guanidine  isothiocyanate  phenol-chloroform
extraction method.30 RNA yield was quantified
spectrophotometrically  and  A260/A280  ratios
determined. The integrity and accuracy of the
spectrophotometric measurement of each RNA
sample was assessed by electrophoresis of 1 ʼg
on  an  ethidium  bromide-stained,  agarose
minigel. Equal amounts of total RNA (0.5 ʼg)
were reverse transcribed into cDNA using oligo
dT. cDNA was subsequently amplified by the
polymerase chain reaction (PCR) in the pres-
ence  of  specific  primers  according  to  the
instructions  provided  by  the  manufacturer
(GeneAmp RNA PCR Kit, Perkin-Elmer Cetus).
The PCR was performed using the following
primers  and  conditions:  for  MDR-3,
5’CATCAGCCCTGTTCTTGGACT3’,  5’GAGAT-
GTTGGCCGTGATAGCT3  ’(234-bp  fragment);
94°C for 30 s, 58°C for 60 s, and 72°C for 60 s
for  30  cycles.  For  ACAT-1,  5’TGCCTGAGC-
TACTTCTACCCA3’,  5’CACGTAACGACAAGTCCA
GGT3’ (266-bp fragment); 95°C for 30 s, 60°C
for 30 s, and 72°C for 40 s, for 30 cycles. For
caveolin-1,  5’CTACAAGCCCAACAACAAGGC  3’,
5’AGGAAGCTCTTGATGCACGGT 3’ (340 bp frag-
ment); 965°C for 25 s, 58°C for 30 s, and 73°C
for 50 s, for 30 cycles. For ʲ-actin, 5’GCCTCTG-
GTCGTACCACTGGC3’,  5’AGGGAGGAAGAGGAT-
GCGGCA3’ (278 bp fragment); 95°C for 30 sec-
onds, 59°C for 30 seconds, and 72°C for 45 sec-
onds,  for  30  cycles.  Preliminary  experiments
demonstrated that using these PCR conditions
the  amount  of  product  amplification  to  RNA
relationship was linear for the cycle number
used over the range 500-1500 ng of total RNA.
Working in these conditions PCR products sep-
arated on agarose and stained with ethidium
bromide were characterized by a major band of
the predicted size (data not shown).
Blotting analysis 
During  PCR  reaction  the  nonradioactive
label  Digoxigenin-11-dUTP  (DIG;  Boheringer
Mannheim) was incorporated and immunode-
tected  with  anti-digoxigenin  Fab  fragments
conjugated to alkaline phosphatase and visual-
ized  with  the  chemiluminescence  substrate
CSPD®.  Enzymatic  dephosphorylation  of
CSPD® by alkaline phosphatase led to a light
emission at a maximum wavelength of 477 nm
which was recorded on X-ray films. The DNA
fragments  were  separated  by  electrophoresis
on agarose and then blotted onto a nylon mem-
brane for 16 h in 10XSSC. The blot was exposed
to X-ray film for 2-10 minutes. A Kodak Digital
Science Band Scanner Image Analysis System
containing  HP  ScanJet,  ID  Image  Analysis
Software assessed the intensity of the bands in
the autoradiograms. The overall procedure was
standardized by expressing the amount of PCR
product for each target mRNA relative to the
amount of product formed for ʲ-actin. Since a
low  yield  of  PCR  products  is  often  obtained
when cDNA segments are coamplified with an
internal standard gene in the same tube, the
relative levels of gene expression were deter-
mined by comparing the PCR products of the
target cDNA and ʲ-actin gene processed in sep-
arate tubes.
Microscopic analysis
For  microscopic  analysis,  MELC,  grown  in
suspension as described above, were treated
with 5 mM HMBA or with 4  ʼM of the acyl
amide ACAT inhibitor SaH 58-035 (SaH) kindly
provided  by  Novartis  Pharma  AG,  Basel,
Switzerland and harvested after 72 h. To visual-
ize the degree of cytoplasmic neutral lipid (NL)
accumulation, MELC were washed three times
with PBS, and fixed by soaking in 10% forma-
lin. Cells were then treated with isopropyl alco-
hol (60%), washed, and stained with oil red O
(ORO)  (a  lipid-soluble  dye  which  stains  NL,
including CE, but not FC) and then counter-
stained with Mayer’s hematoxylin NL appear as
bright red spots in the cytoplasm. Cells were
imaged  using  a  Leitz  inverted-phase  micro-
scope fitted with a digital camera. 
Statistical analysis 
Data  were  reported  as  the  average
values±standard  error  (SE).  Student’s  t-test,
suitably  computed  by  means  of  the  grouped
data method, was used, and a probability value
of P<0.05 was regarded as statistically signifi-
cant. 
Results 
Inhibition of cell growth of MELC by
HMBA
When the rate of cell proliferation was ana-
lyzed,  about  65%  fewer  cells  were  found  in
HMBA-induced cultures compared to uninduced
after 3 days of culturing, when the cultures were
approaching confluence (P<0.05) (Figure 1A).
Similarly, the rate of  3H-thymidine incorpora-
tion was consistently higher in MELC than in
HMBA-treated cells (Figure 1B). The increased
ability  to  growth  in  MELC  compared  with
HMBA-cells was also reflected in a higher con-
tent of proteins in the former compared with the
latter (Figure 1C).
Inhibition of cholesterol esterifica-
tion in MELC by HMBA 
Cholesterol biosynthesis and esterification in
MELC and HMBA-MELC were assessed as an
indirect  measure  of  changes  in  intracellular
cholesterol  content.  The  rate  of  (14C)acetate
incorporation into FC in control cells was almost
twice that in HMBA cells (P<0.05) (Figure 2A).
When  the  rate  of  (14C)acetate  incorporation
into CE was assessed (Figure 2B), a 2-to 10-fold
lower CE synthesis was observed in HMBA cells.
Accordingly, the rate of (14C)oleic acid incorpo-
ration into CE in HMBA cells was at least 60%
lower compared with that in uninduced MELC
cells (P<0.05) (Figure 2C).
PCR analysis in MELC and HMBA-
cells 
To further evaluate the possibility that cho-
lesterol esterification per se may be a limiting
factor in determining cell growth and differenti-
ation, we next evaluated in MELC and HMBA-
cells, the expression of some genes implicated
in  the  regulation  of  intracellular  cholesterol
trafficking: ACAT-1 and MDR-3, involved in the
import  of  cholesterol,  and  caveolin-1,  in  the
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export.  The  detection  of  ACAT-1,  MDR-3  and
caveolin-1 mRNAs has been carried out by PCR
on  reverse  transcripts,  and  analyses  have
revealed  the  occurrence  of  PCR  products
migrating  at  positions  consistent  with  the
expected size of 266 bp, 234-bp, 340 bp, respec-
tively (data not shown). Growing MELCs were
found to express relatively high levels of ACAT-1
and  MDR-3  mRNAs,  which  significantly
decreased during MELC induction to terminal
division by 5 mM HMBA, (Figures 3 and 4 A and
B).  By  contrast,  caveolin-1  gene  expression,
powerfully suppressed in growing MELC, aug-
mented in HMBA-induced cells (Figures 3 and
Figure 4C).
Microscopic analysis 
Finally, to examine the effects of pharmaco-
logical inhibition of cholesterol esterification on
cell growth and differentiation, we compared the
effects  of  HMBA  with  those  of  SaH  58-035
(SaH), a specific inhibitor of ACAT, especially
with  regard  to  morphologic  and  neutral  lipid
changes on MELC cultures. The results showed
that, MELC, 72 h after SaH-treatment, are small-
er and have smaller nuclei compared to untreat-
ed cells, in that resembling the 72 h HMBA-treat-
ed cells (Figure 5A). On the other hand, detec-
tion  of  cytoplasmic  neutral  lipids  by  staining
MELC with ORO, a dye able to evidence CE but
not FC, revealed that HMBA-treatment inhibits
Article
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Figure 1. Time course of cell growth, 3H-
thymidine incorporation and protein con-
tent  in  murine  erythroleukemia  cells
(MELC) in presence or absence of hexam-
ethylene  bisacetamide  (HMBA).  MELC
cells  were  seeded  at  a  density  of  1ﾥ105
cells/mL  and  stimulated  to  growth  by
adding 10% FCS. At the indicated times A)
cell number, B)  3H-thymidine incorpora-
tion  and  C)  protein  content  were  deter-
mined  as  described  in  Materials  and
Methods. Data are mean±Standard Error of
three independent experiments, each per-
formed in triplicate. *Indicates statistically
significant  (P<0.05)  compared  with
MELC. 
Figure 2. Time course of 14C-acetate incor-
porated into A) free cholesterol, B) coles-
terol esters and C) 14C-oleate incorpora-
tion into Colesterol Esters of murine ery-
throleukemia cells (MELC) in presence or
absence  of  hexamethylene  bisacetamide
(HMBA). MELC cells were seeded at a den-
sity of 1ﾥ105 cells/mL and stimulated to
growth  by  adding  10%  FCS  14C-acetate
and 14C-oleate were added 3 h before each
time point. MELC were harvested every 24
h  for  a  total  period  of  96  h.  Data  are
mean±Standard Error of three independent
experiments, each performed in triplicate.
*Indicates statistically significant (P<0.05)
compared with MELC. 
Figure 4. Relative levels of Acyl-coenzyme A:
Cholesterol  AcylTransferase  (ACAT-1),
Multidrug  Resistance  (MDR-3)  and
Caveolin-1  (C)  mRNA  in  murine  ery-
throleukemia  cells  (MELC).  Reverse  tran-
scription-polymerase chain reaction analysis
was performed for three independent exper-
iments.  Relative  levels  of  A)  ACAT-1,  B)
MDR-3 and C) Caveolin-1 (Cav-1) mRNA
were  normalized  to  the  corresponding  ʲ-
actin levels and expressed as percentage.
Figure  3.  Multidrug  Resistance  (MDR-1),
Acyl-coenzyme  A:  Cholesterol  Acyl
Transferase (ACAT-1) and Caveolin-1 mRNA
levels  in  murine  erythroleukemia  cells
(MELC)  and  hexamethylene  bisacetamide
(HMBA)-induced MELC. The figure shows
representative  autoradiograms  of  MDR-1,
ACAT-1,  caveolin-1  (Cav-1)  and  ʲ-actin
mRNA  in  MELC  and  in  HMBA  treated
MELC.  Reverse  transcription-polymerase
chain  reaction  analysis  was  performed  as
described in Materials and Methods.[page 56] [Hematology Reports 2011; 3:e19]
cholesterol  ester  accumulation  in  MELC  to
approximately  the  same  extent  as  the  ACAT
inhibitor, SaH (Figure 5B). 
Discussion 
This study attempts to evaluate a possible
role of cholesterol esterification in the regula-
tion of cell growth and differentiation. To do
this, we utilized MELC as a model of cell differ-
entiation by using either uninduced or HMBA-
induced  cultures  as  actively  proliferating  or
differentiating cell populations, respectively. It
was found that cholesterol esterification is i)
enhanced during active DNA synthesis and ii)
inhibited concomitantly with pharmacological-
ly-induced  cell  differentiation  and  growth
arrest.  Particularly,  the  rate  of  cholesterol
esterification seems to parallel cellular replica-
tion and, actually, precedes the onset of DNA
synthesis.  Intracellular  cholesterol  transport
are  now  receiving  increasing  attention  as
devices that cholesterol in specialized mem-
brane platform called rafts could have a role in
the regulation of a number of signal transduc-
tion pathways, including those involved in cell
division  and  differentiation.31 Studies  with
cholesterol-depleted cells demonstrated that a
reduced level of cholesterol in the rafts is by
itself a signal to activate pathway leading to
cell division.32,33 ACAT-1, MDR-3 and caveolin-
1 are a part of the lipid transport system that
counterbalances  excessive  intracellular  cho-
lesterol.  It  has  been  suggested  that  MDR-3
transports excess cholesterol from the plasma
membrane  to  ER  where  it  is  esterified  by
ACAT.24,25 On  the  contrary,  caveolin-1  trans-
ports cholesterol from ER to plasma membrane
where  it  become  the  preferential  source  of
cholesterol for efflux.27,28 As an essential com-
ponent of caveolae, caveolin-1 is also involved
in  numerous  signalling  pathways.32-34
Involvement  of  these  proteins  in  cholesterol
trafficking  makes  them  potential  targets  to
improve our knowledge on the possible role of
cholesterol  esterification  in  stimulation  of
growth and differentiation. In this work, we
demonstrate  that  down-regulation  of  ACAT-1
and MDR-3 and up-regulation of caveolin-1 in
MELC are strictly correlated with cell differen-
tiation induced by HMBA. These findings raise
the  possibility  that  MDR-3  and  caveolin-1,
might  specifically  influence  raft-dependent
signal transduction, at least in part, so rein-
forcing the possibility that cholesterol esterifi-
cation, MDR-1, caveolin-1 and signal transduc-
tion may be closely linked. The view is consis-
tent with the induction of MDR-3- and ACAT-1
and with the reduction of caveolin-1 mRNA in
MELC cell growing, and with the opposite pat-
tern observed in differentiating cells. Further
studies  are  necessary  to  provide  a  complete
mechanistic  understanding  of  exactly  how
cholesterol esterification regulates cell differ-
entiation, however, we could reach a tentative
hypothesis:  when  cells  are  stimulated  to
divide,  such  as  during  tumorigenesis,  the
intracellular cholesterol increases, however it
beside to be transported and distributed with-
in the plasma membranes in lipid rafts, accu-
mulate  in  the  cytoplasm  as  CE.  The  conse-
quent  lower  levels  of  FC  into  the  rafts,  by
actively enhancing the integrated interchange
of signaling molecules involved in cell division,
such as Ras-MAPK cascade, may contribute to
accelerate  tumor  progression.35 Conversely,
when  cells  are  stimulated  to  differentiation,
the inhibition of cholesterol esterification, by
increasing  the  expression  of  caveolin-1  and
possibly FC content into the rafts, may lead to
a  reduction  of  signal  transduction  activa-
tion.32,33,35 Proliferating tumor cells, could be
then  reprogrammed  to  terminal  division
toward the mature phenotype with consequent
loss of tumorigenicity. 
Conclusions
The results of this study, other than to add
new insights on the possible role of cholesterol
metabolism during tumor growth, for the first
time indicate a role of cholesterol esterifica-
tion and of some related genes in differentia-
tion of erythroid cells. These findings raise the
possibility that cholesterol esterification and
related genes may emerge as a successful ther-
apeutic targets for disease characterized by a
block in differentiation, i. e. leukemias. 
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